Literature DB >> 31868768

Primary Aldosteronism: Cardiovascular Risk, Diagnosis, and Management.

Padma Raghavan Pillai1, Mindy Griffith, Monica D Schwarcz, Irene A Weiss.   

Abstract

Primary aldosteronism remains a leading cause of secondary hypertension, and its diagnosis and management continue to pose a challenge for clinicians. In this article, we review the diagnosis of primary aldosteronism along with its cardiovascular manifestations. Treatment is described depending on the diagnostic outcome, focusing on medical management with mineralocorticoid receptor antagonists and unilateral adrenalectomy. Although screening and diagnosing hyperaldosteronism follows well-known algorithms, in practice, physicians may find difficulty establishing the best course of action due to complexity in testing and confirming laterality of aldosterone production by the adrenals. Recognizing and treating primary aldosteronism requires a multidisciplinary approach with primary care physicians, cardiologists, endocrinologists, and radiologists working collaboratively.

Entities:  

Mesh:

Year:  2020        PMID: 31868768     DOI: 10.1097/CRD.0000000000000281

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  6 in total

1.  Bilateral Adrenalectomy in a Patient With Refractory Primary Aldosteronism Due to Adrenal Hyperplasia.

Authors:  Luis Marín-Martínez; Antonio J Ríos-Vergara; Georgios Kyriakos; Maria C Álvarez-Martín; Enrique Hernández-Alonso
Journal:  Cureus       Date:  2022-04-19

Review 2.  DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases.

Authors:  Yoshimichi Takeda; Masashi Demura; Takashi Yoneda; Yoshiyu Takeda
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

3.  Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis.

Authors:  Yaqiong Zhou; Dan Wang; Licheng Jiang; Fei Ran; Sichao Chen; Peng Zhou; Peijian Wang
Journal:  BMJ Open       Date:  2020-12-31       Impact factor: 2.692

4.  Concurrent Primary Aldosteronism and Renal Artery Stenosis: An Overlooked Condition Inducing Resistant Hypertension.

Authors:  Lin Zhao; Jinhong Xue; Yi Zhou; Xueqi Dong; Fang Luo; Xiongjing Jiang; Xinping Du; Xianliang Zhou; Xu Meng
Journal:  Front Cardiovasc Med       Date:  2022-03-03

Review 5.  Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis.

Authors:  Ningjing Qian; Jingmiao Xu; Yaping Wang
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-08

6.  New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies.

Authors:  Cheng-Hsuan Tsai; Ya-Li Chen; Chien-Ting Pan; Yen-Tin Lin; Po-Chin Lee; Yu-Wei Chiu; Che-Wei Liao; Zheng-Wei Chen; Chin-Chen Chang; Yi-Yao Chang; Chi-Sheng Hung; Yen-Hung Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.